Request Sample Inquiry
Asthma and Copd Drugs Market

Asthma and COPD Drugs Market

Asthma and COPD Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

199

Base Year:

2023

Date

Apr - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2464

Segments Covered
  • By Diseases By Diseases Asthma, COPD
  • By Medication Class By Medication Class Combination Drugs, Bronchodilators, Inhaled Corticosteroids (ICS), Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Anti-Inflammatories, Other Classes
  • By Distribution Channel By Distribution Channel Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 37.42 Billion
Revenue 2032Revenue 2032: USD 57.56 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 4.9%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Europe
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Asthma and COPD Drugs Market Segment Analysis

  • Asthma and COPD Drugs Diseases Outlook (Revenue, USD Million, 2018 - 2030)
    • Asthma
    • COPD
  • Asthma and COPD Drugs Medication Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Combination Drugs
    • Bronchodilators
    • Inhaled Corticosteroids (ICS)
    • Short Acting Beta Agonists (SABA)
    • Long Acting Beta Agonists (LABA)
    • Leukotriene Antagonists (LTA)
    • Anticholinergics
    • Anti-Inflammatories
    • Other Classes
  • Asthma and COPD Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
    • Drug Stores
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Asthma and COPD Drugs Market, by Diseases
        • Asthma
        • COPD
      • North America Asthma and COPD Drugs Market, by Medication Class
        • Combination Drugs
        • Bronchodilators
        • Inhaled Corticosteroids (ICS)
        • Short Acting Beta Agonists (SABA)
        • Long Acting Beta Agonists (LABA)
        • Leukotriene Antagonists (LTA)
        • Anticholinergics
        • Anti-Inflammatories
        • Other Classes
      • North America Asthma and COPD Drugs Market, by Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Online Pharmacies
        • Drug Stores
      • U.S.
        • U.S. Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • U.S. Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • U.S. Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Canada
        • Canada Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Canada Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Canada Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Mexico
        • Mexico Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Mexico Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Mexico Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
    • Europe
      • Europe Asthma and COPD Drugs Market, by Diseases
        • Asthma
        • COPD
      • Europe Asthma and COPD Drugs Market, by Medication Class
        • Combination Drugs
        • Bronchodilators
        • Inhaled Corticosteroids (ICS)
        • Short Acting Beta Agonists (SABA)
        • Long Acting Beta Agonists (LABA)
        • Leukotriene Antagonists (LTA)
        • Anticholinergics
        • Anti-Inflammatories
        • Other Classes
      • Europe Asthma and COPD Drugs Market, by Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Online Pharmacies
        • Drug Stores
      • U. K.
        • U.K. Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • U.K. Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • U.K. Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • France
        • France Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • France Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • France Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Germany
        • Germany Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Germany Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Germany Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Italy
        • Italy Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Italy Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Italy Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Spain
        • Spain Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Spain Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Spain Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Rest of Europe
        • Rest of Europe Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Rest of Europe Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Rest of Europe Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
    • Asia Pacific
      • Asia Pacific Asthma and COPD Drugs Market, by Diseases
        • Asthma
        • COPD
      • Asia Pacific Asthma and COPD Drugs Market, by Medication Class
        • Combination Drugs
        • Bronchodilators
        • Inhaled Corticosteroids (ICS)
        • Short Acting Beta Agonists (SABA)
        • Long Acting Beta Agonists (LABA)
        • Leukotriene Antagonists (LTA)
        • Anticholinergics
        • Anti-Inflammatories
        • Other Classes
      • Asia Pacific Asthma and COPD Drugs Market, by Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Online Pharmacies
        • Drug Stores
      • China
        • China Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • China Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • China Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Japan
        • Japan Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Japan Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Japan Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Germany
        • Germany Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Germany Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Germany Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • India
        • India Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • India Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • India Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • South Korea
        • South Korea Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • South Korea Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • South Korea Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • South East Asia
        • South East Asia Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • South East Asia Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • South East Asia Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Rest of Asia Pacific
        • Rest of Asia Pacific Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Rest of Asia Pacific Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Rest of Asia Pacific Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
    • Latin America
      • Latin America Asthma and COPD Drugs Market, by Diseases
        • Asthma
        • COPD
      • Latin America Asthma and COPD Drugs Market, by Medication Class
        • Combination Drugs
        • Bronchodilators
        • Inhaled Corticosteroids (ICS)
        • Short Acting Beta Agonists (SABA)
        • Long Acting Beta Agonists (LABA)
        • Leukotriene Antagonists (LTA)
        • Anticholinergics
        • Anti-Inflammatories
        • Other Classes
      • Latin America Asthma and COPD Drugs Market, by Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Online Pharmacies
        • Drug Stores
      • Brazil
        • Brazil Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Brazil Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Brazil Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Argentina
        • Argentina Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Argentina Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Argentina Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Rest of Latin America
        • Rest of Latin America Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Rest of Latin America Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Rest of Latin America Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
    • Middle East & Africa
      • Middle East & Africa Asthma and COPD Drugs Market, by Diseases
        • Asthma
        • COPD
      • Middle East & Africa Asthma and COPD Drugs Market, by Medication Class
        • Combination Drugs
        • Bronchodilators
        • Inhaled Corticosteroids (ICS)
        • Short Acting Beta Agonists (SABA)
        • Long Acting Beta Agonists (LABA)
        • Leukotriene Antagonists (LTA)
        • Anticholinergics
        • Anti-Inflammatories
        • Other Classes
      • Middle East & Africa Asthma and COPD Drugs Market, by Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • Online Pharmacies
        • Drug Stores
      • GCC Countries
        • GCC Countries Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • GCC Countries Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • GCC Countries Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • South Africa
        • South Africa Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • South Africa Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • South Africa Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Asthma and COPD Drugs Market, by Diseases
          • Asthma
          • COPD
        • Rest of Middle East & Africa Asthma and COPD Drugs Market, by Medication Class
          • Combination Drugs
          • Bronchodilators
          • Inhaled Corticosteroids (ICS)
          • Short Acting Beta Agonists (SABA)
          • Long Acting Beta Agonists (LABA)
          • Leukotriene Antagonists (LTA)
          • Anticholinergics
          • Anti-Inflammatories
          • Other Classes
        • Rest of Middle East & Africa Asthma and COPD Drugs Market, by Distribution Channel
          • Retail Pharmacies
          • Hospital Pharmacies
          • Online Pharmacies
          • Drug Stores
FAQ
Frequently Asked Question
  • The global Asthma and COPD Drugs valued at USD 37.42 Billion in 2023 and is expected to reach USD 57.56 Billion in 2032 growing at a CAGR of 4.9%.

  • The prominent players in the market are Novartis AG (Switzerland), Cipla Inc. (India), Abbott Laboratories (U.S.), Astellas Pharma (Japan), Hoffmann-La Roche Ltd. (Switzerland), Glenmark Pharmaceuticals (India), Verona Pharma PLC (UK), AstraZeneca (UK), GSK (UK), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co. Inc. (U.S.), Grifols S.A. (Spain).

  • The market is project to grow at a CAGR of 4.9% between 2024 and 2032.

  • The driving factors of the Asthma and COPD Drugs include

    • The rising incidence of asthma and COPD globally is a significant driver for the market, primarily fueled by several interconnected factors

  • North America was the leading regional segment of the Asthma and COPD Drugs in 2023.